NovaBay Pharmaceuticals, Inc.
(NYSE Amex Equities : NBY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.57%93.761.3%$1006.11m
BIIBBiogen Inc.
-0.35%226.391.3%$952.73m
AMGNAmgen Inc.
-2.74%177.471.3%$455.04m
GILDGilead Sciences, Inc.
-0.47%62.950.9%$420.88m
ILMNIllumina, Inc.
0.11%319.033.5%$281.15m
REGNRegeneron Pharmaceuticals, Inc.
-2.81%333.342.6%$259.19m
VRTXVertex Pharmaceuticals Incorporated
0.71%168.161.9%$237.18m
ALXNAlexion Pharmaceuticals, Inc.
0.08%126.012.0%$169.88m
ONCESpark Therapeutics, Inc.
-0.08%110.6211.2%$168.64m
EXASExact Sciences Corporation
0.44%92.2125.3%$159.86m
SRPTSarepta Therapeutics, Inc.
-1.76%116.6414.7%$145.69m
AAgilent Technologies, Inc.
0.99%76.181.6%$128.52m
INCYIncyte Corporation
-0.48%73.962.5%$95.36m
IONSIonis Pharmaceuticals, Inc.
0.44%72.998.3%$93.24m
BMRNBioMarin Pharmaceutical Inc.
0.98%83.164.3%$89.86m

Company Profile

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.